Allogene Therapeutics, headquartered in South San Francisco, announced it will participate in an investor conference hosted by Citibank.
2 reports, 2 independent
Updated Aug 27
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Allogene Therapeutics, headquartered in South San Francisco, announced it will participate in an investor conference hosted by Citibank.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Allogene Therapeutics is participating in Citi's investor conference from its HQ in South San Francisco.1 source
The company is highlighted for its potential value and growth to investors.1 source
Keep exploring
The entities involved
-
Allogene Therapeutics (United States)
company in San Francisco, United States
Nothing else this week.
-
Citibank
American multinational bank
Coverage
Newest first; wire copies grouped- GlobeNewswireAllogene Therapeutics Announces Participation in Upcoming Investor Conference SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-sta
- Simply Wall St.Allogene Therapeutics And 2 Other Promising Penny Stocks To Watch In the last week, the market has stayed flat, but it is up 11% over the past year with earnings expected to grow by 15% per annum in